Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,536 | -14,548 | -16,337 | -5,101 | -1,406 |
| Depreciation Amortization | 569 | 568 | 543 | 185 | 41 |
| Other Working Capital | -2,917 | 2,217 | 3,997 | -3,174 | -489 |
| Other Operating Activity | 4,015 | 5,376 | -264 | -24 | 357 |
| Operating Cash Flow | $-6,869 | $-6,387 | $-12,060 | $-8,114 | $-1,497 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -424 | -1,847 | -918 | -814 | -36 |
| Net Acquisitions | 0 | 0 | -39 | 0 | 0 |
| Other Investing Activity | 54 | 40 | 273 | 0 | 0 |
| Investing Cash Flow | $-370 | $-1,807 | $-685 | $-814 | $-36 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | -717 | 0 | 0 |
| Other Financing Activity | 1,120 | 14,888 | 7,597 | 13,503 | 3,139 |
| Financing Cash Flow | $1,120 | $14,888 | $6,880 | $13,503 | $3,139 |
| Exchange Rate Effect | 20 | -240 | 362 | 0 | 0 |
| Beginning Cash Position | 7,141 | 687 | 6,190 | 1,615 | 9 |
| End Cash Position | 1,041 | 7,141 | 687 | 6,190 | 1,615 |
| Net Cash Flow | $-6,100 | $6,454 | $-5,503 | $4,575 | $1,606 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,869 | -6,387 | -12,060 | -8,114 | -1,497 |
| Free Cash Flow | -6,869 | -6,387 | -12,060 | -8,114 | -1,497 |